Pursuant to 21 CFR 1301.33(a), this is notice that on July 8, 2004, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed:
| Drug | Schedule |
|---|---|
| N-Ethylamphetamine (1475) | I |
| 4-Methoxyamphetamine (7411) | I |
| 2,5-Dimethoxyamphetamine (7396) | I |
| Difenoxin (9168) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Methylphenidate (1724) | II |
| Pentobarbital (2270) | II |
| Secobarbital (2315) | II |
| Codeine (9050) | II |
| Oxycodone (9143) | II |
| Diphenoxylate (9170) | II |
| Hydrocodone (9193) | II |
| Meperidine (9230) | II |
| Dextropropoxyphene, bulk (9273) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Alfentanil (9737) | II |
| Sufentanil (9740) | II |
| Fentanyl (9801) | II |
The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than December 13, 2004.
Dated: September 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 04-22935 Filed 10-12-04; 8:45 am]
BILLING CODE 4410-09-P